81 FR 1194 - Meeting of the National Vaccine Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 81, Issue 6 (January 11, 2016)

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting February 2-3, 2016. The meeting is open to the public. However, pre- registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/. Participants may also register by emailing [email protected] or by calling 202-690-5566 and providing their name, organization, and email address.

[Federal Register Volume 81, Number 6 (Monday, January 11, 2016)]
[Notices]
[Pages 1194-1195]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-00319]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
February 2-3, 2016. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/. Participants may also register by emailing 
[email protected] or by calling 202-690-5566 and providing their name, 
organization, and email address.

DATES: The meeting will be held on February 2-3, 2016. The meeting 
times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/ as soon as they become 
available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, the Great Hall, 200 Independence Avenue SW., 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/index.html.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The February 2016 NVAC meeting agenda will include discussions on 
mechanisms to support vaccine development and innovation, vaccine 
pricing and purchasing behaviors in the private vaccine market, and 
quality measures for adult immunizations. The NVAC will hear an update 
on progress towards a mid-course review of the 2010 National Vaccine 
Plan, as well as an update from the NVAC Maternal Immunizations Working 
Group. Committee members also will be provided information on ongoing 
Departmental efforts to support the pre-departure vaccination of U.S.-
bound refugees. Please note that agenda items are subject to change as 
priorities dictate. Information on the final meeting agenda will be 
posted prior to the meeting on the NVAC Web site: http://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend in person and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the National Vaccine Program Office at 
the address/phone listed above at least one week prior to the meeting. 
For those unable to attend in person, a live webcast will be available. 
More information on registration and accessing the webcast can be found 
at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. It 
is requested that individuals submitting written comments email their 
comments to the National Vaccine Program Office ([email protected]) at least 
five business days prior to the meeting.


[[Page 1195]]


    Dated: January 5, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2016-00319 Filed 1-8-16; 8:45 am]
 BILLING CODE 4150-44-P